Maharashtra Herald

Creative Biolabs Introduces Novel CAR-T Therapy Development Services at 10th Immuno-Oncology Summit

 Breaking News
  • No posts were found

Creative Biolabs Introduces Novel CAR-T Therapy Development Services at 10th Immuno-Oncology Summit

October 19
00:33 2022
Creative Biolabs is honored to participate in the 10th Immuno-Oncology Summit and showcase the latest CRO services for CART-T therapy development at booth #9 as the exhibitor.

New York, USA – October 18, 2022 – As a leading annual meeting focusing on the latest applied research, Immuno-Oncology Summit held by Cambridge Healthtech Institute (CHI) has ushered the 10th annual meeting on October 12, 2022, providing in-depth coverage across all modalities and stages in the immuno-oncology development pipeline. Creative Biolabs is honored to participate in this great event as the corporate support sponsor and showcase the latest CRO services for CART-T therapy development at booth #9 as the exhibitor.

With years of striving for excellence, Creative Biolabs has gathered a team of experts, achieved quantities of challenging cases for customers, and won great reputations among global users in the field of cell therapy development, with powerful innovation, exceptional creativity, and a true passion. The scientist representatives have been delighted to introduce an upgraded novel pipeline of drug discovery and development solutions at the 10th Immuno-Oncology Summit, covering:

* CAR-T Therapy Development Services

* TCR Modified T Cell Development Services

* Cancer Vaccine Development Services

* Dendritic Vaccine Development Services

* TCR-Like Antibody Services

* CAR-Macrophage Therapy Development Services

“We also met many leading researchers and companies from industry and academia during the summit, and their discussions about novel engineering approaches, allogeneic platforms, preclinical and clinical updates, plus the latest approaches to improve product safety and efficacy are very inspiring for us to keep innovating our platforms and improving our workflow.” said a Creative Biolabs scientist representative who has attended the summit.

This event has come to a successful conclusion and taking this opportunity, Creative Biolabs would like to thank the staff from CHI for their excellent organization, all the speakers for their brilliant presentations, and all the guests who came to visit booth #9. The on-site scientist team elaborately prepared gifts and brochures and hope that all the visitors enjoyed the gifts and came away with relevant solutions to their inquiries.

On December 4-8, 2022, Creative Biolabs will participate in the Antibody Engineering & Therapeutics (US) in San Diego, CA, and look forward to meeting more friends at booth #418.

Explore innovative cell therapy solutions and stay up-to-date on upcoming events at https://www.creative-biolabs.com/car-t.

About Creative Biolabs

With years of exploration in biotechnology, Creative Biolabs has gathered talented scientists working closely with worldwide partners to develop and produce medicines of tomorrow. Specifically, Creative Biolabs specializes in one-stop custom services for CAR-T therapy development, dendritic cell therapy development, TCR modified T cell development, CAR-macrophage therapy development, cancer vaccine development, etc.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/car-t